whoa. whoa. whoa.

You're being directed to the ELOCTATE Healthcare Professional website. If you're okay with that, we're okay with that.

Come back soon!

Let's keep in touch

Sign up to receive information and tools to help you and your healthcare provider decide if ELOCTATE is right for you. You will also be contacted by a CoRe Manager who will answer your questions and help you navigate our various resources.

error icon
error icon
error icon
error icon
error icon
error icon

Prophy

On Demand

Not applicable / Prefer not to say

error icon

I am interested in learning more about ELOCTATE

I am (or my child is) currently on ELOCTATE

error icon

I am someone with Hemophilia A

I am a caregiver

Other

error icon

You must be thirteen (13) years or older to enroll. If you are aged 13 to 18, you should get your parent's or guardian's permission before providing your personal health information. We will not sell or transfer your Personal Data to any unrelated third party for marketing purposes without your express permission.

SANOFI GLOBAL PRIVACY POLICY TERMS AND CONDITIONS

By submitting the following information, you are agreeing that Sanofi Rare Blood Disorders and its agents (such as third-party business partners) may contact you by mail, email, fax, and/or telephone, including calls and text messages made using an automatic telephone dialing system or prerecorded voice at the telephone number(s) provided, to send you information about relevant Sanofi products, promotions, services, and research studies, ask your opinion about such information and topics, including through market research and disease-related surveys, and share the information you provide with one another to perform these activities and to de-identify it for use in performing research, education, business analytics, marketing studies, and other commercial purposes. Text message rates may apply. Your information will not be sold to any third party but may be provided to regulatory authorities if required.

You may have certain rights under applicable data privacy laws regarding your personal information, including the right to access your personal information held by Sanofi. For further information regarding these rights, please reference our Global Privacy Policy.

error icon

IMPORTANT SAFETY INFORMATION AND INDICATIONS

+

IMPORTANT SAFETY INFORMATION

Do not use ELOCTATE if you have had an allergic reaction to it in the past.

Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.

Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.

Your body can also make antibodies called "inhibitors" against ELOCTATE, which may stop ELOCTATE from working properly.

Additional common side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort.

If you have risk factors for developing abnormal blood clots in your body, such as an indwelling venous catheter, treatment with Factor VIII may increase this risk.

These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, or if bleeding is not controlled after using ELOCTATE.

INDICATIONS

ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.

PLEASE SEE FULL PRESCRIBING INFORMATION

MANUFACTURED BY

Bioverativ Therapeutics Inc.
Waltham, MA 02451 USA
U.S. License #2078

CLICK HERE TO LEARN MORE ABOUT SANOFI'S COMMITMENT TO FIGHTING COUNTERFEIT DRUGS.